Our mission is to promote cancer epigenetics research to:

• help discover novel epigenetics modifiers and mechanisms
• help understand the molecular epigenetic mechanisms that lead to cancer, metastasis, minimal residual disease, therapy response or resistance, and modulation of the tumor microenvironment or the immune system
• help discover epigenetic mechanisms that can serve as diagnosis tools for the early detection of cancers, metastases, or cancer relapse
• help discover epigenetic mechanisms or biomarkers that can serve as prognosis factors for treatment response and long-term survival
• help discover epigenetic mechanisms or biomarkers that can serve as novel drug targets
• help discover epigenetics-based personalized cancer medicine for improved remission rates, patient survival, and quality of life

We implement to that effect and integrative approach based on promoting basic, translational, and clinical research, helping and supporting scientists at all levels, bringing together the best talents in cancer science and medicine, and making sure that the most promising and reproducible research is quickly brought to the attention of clinicians to rapidly benefit patients that may need it the most.